Active Biotech (Sweden) Market Value
| ACTI Stock | SEK 0.27 0.02 8.00% |
| Symbol | Active |
Active Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Active Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Active Biotech.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Active Biotech on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Active Biotech AB or generate 0.0% return on investment in Active Biotech over 30 days. Active Biotech is related to or competes with Cantargia, BioArctic, Oncopeptides, Hansa Biopharma, and BioInvent International. Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunit... More
Active Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Active Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Active Biotech AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 13.13 | |||
| Information Ratio | 0.0493 | |||
| Maximum Drawdown | 199.15 | |||
| Value At Risk | (20.83) | |||
| Potential Upside | 27.78 |
Active Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Active Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Active Biotech's standard deviation. In reality, there are many statistical measures that can use Active Biotech historical prices to predict the future Active Biotech's volatility.| Risk Adjusted Performance | 0.0514 | |||
| Jensen Alpha | 1.52 | |||
| Total Risk Alpha | (3.00) | |||
| Sortino Ratio | 0.1 | |||
| Treynor Ratio | (2.21) |
Active Biotech AB Backtested Returns
Active Biotech is out of control given 3 months investment horizon. Active Biotech AB secures Sharpe Ratio (or Efficiency) of 0.0562, which signifies that the company had a 0.0562% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.51% are justified by taking the suggested risk. Use Active Biotech Mean Deviation of 11.35, risk adjusted performance of 0.0514, and Downside Deviation of 13.13 to evaluate company specific risk that cannot be diversified away. Active Biotech holds a performance score of 4 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.65, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Active Biotech are expected to decrease at a much lower rate. During the bear market, Active Biotech is likely to outperform the market. Use Active Biotech total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to analyze future returns on Active Biotech.
Auto-correlation | -0.1 |
Very weak reverse predictability
Active Biotech AB has very weak reverse predictability. Overlapping area represents the amount of predictability between Active Biotech time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Active Biotech AB price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Active Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Active Biotech AB lagged returns against current returns
Autocorrelation, which is Active Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Active Biotech's stock expected returns. We can calculate the autocorrelation of Active Biotech returns to help us make a trade decision. For example, suppose you find that Active Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Active Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Active Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Active Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Active Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Active Biotech Lagged Returns
When evaluating Active Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Active Biotech stock have on its future price. Active Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Active Biotech autocorrelation shows the relationship between Active Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Active Biotech AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.